2.3817
price up icon8.91%   0.1917
after-market Handel nachbörslich: 2.35 -0.0317 -1.33%
loading
Schlusskurs vom Vortag:
$2.19
Offen:
$2.23
24-Stunden-Volumen:
1.87M
Relative Volume:
1.73
Marktkapitalisierung:
$27.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.36M
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+42.83%
1M Leistung:
+95.51%
6M Leistung:
+4.84%
1J Leistung:
-87.18%
1-Tages-Spanne:
Value
$2.20
$2.47
1-Wochen-Bereich:
Value
$1.60
$3.89
52-Wochen-Spanne:
Value
$0.73
$26.30

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Name
Firmenname
Calidi Biotherapeutics Inc
Name
Telefon
(858) 794-9600
Name
Adresse
4475 Executive Drive, Suite 200, San Diego
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CLDI's Discussions on Twitter

Vergleichen Sie CLDI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
CLDI 2.3817 27.91M 0 -23.36M 0 0.00
VRTX 467.12 119.83B 10.63B -479.80M -1.35B 13.33
REGN 762.38 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 567.35 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.83 24.08B 3.30B -501.07M 1.03B 11.54

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

pulisher
08:26 AM

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer - EIN News

08:26 AM
pulisher
08:00 AM

Calidi Bio's RTNova Shows Promise in Metastatic Lung Cancer Treatment Breakthrough | CLDI Stock News - StockTitan

08:00 AM
pulisher
Nov 15, 2024

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - The Manila Times

Nov 15, 2024
pulisher
Nov 15, 2024

Calidi Biotherapeutics Raises $7.5M Through Public Offering of 4.4M Shares | CLDI Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow

Nov 15, 2024
pulisher
Nov 14, 2024

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Calidi Biotherapeutics Raises $7.5M in Public Offering for Clinical Trials | CLDI Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Surges on 3Q Report, Retreats on Stock-Offer News - MarketWatch

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics plans stock offering - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Launches Public Stock Offering to Fund Corporate Growth | CLDI Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Calidi Bio Gets FDA Nod for Brain Cancer Drug Trial Amid $5.1M Q3 Loss | CLDI Stock | CLDI Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 04, 2024

Calidi Biotherapeutics’ $2.1 Million Shares Offering - Global Legal Chronicle

Nov 04, 2024
pulisher
Nov 02, 2024

Contrasting BioCryst Pharmaceuticals (NASDAQ:BCRX) & Calidi Biotherapeutics (NYSE:CLDI) - Defense World

Nov 02, 2024
pulisher
Oct 31, 2024

CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 31, 2024
pulisher
Oct 29, 2024

Calidi Biotherapeutics’ (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program - Barchart

Oct 29, 2024
pulisher
Oct 25, 2024

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Oct 25, 2024
pulisher
Oct 24, 2024

Calidi to present data supporting RTNova at upcoming conferences - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences - The Manila Times

Oct 24, 2024
pulisher
Oct 24, 2024

Calidi to sell 2.05M shares at $1.00 in registered direct offering - Yahoo Finance

Oct 24, 2024
pulisher
Oct 23, 2024

Calidi Biotherapeutics stock tumbles on $2M securities offering - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

CLDI stock touches 52-week low at $0.95 amid sharp annual decline By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 23, 2024

CLDI stock touches 52-week low at $0.95 amid sharp annual decline - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Why Calidi Biotherapeutics (CLDI) Stock Is Down 13% - Benzinga

Oct 23, 2024
pulisher
Oct 23, 2024

Calidi Biotherapeutics secures $2 million in equity financing - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement - The Manila Times

Oct 23, 2024
pulisher
Oct 19, 2024

Calidi Biotherapeutics Faces Warrant Delisting by NYSE - Yahoo Finance

Oct 19, 2024
pulisher
Oct 19, 2024

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - The Manila Times

Oct 19, 2024
pulisher
Oct 18, 2024

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Oct 18, 2024
pulisher
Oct 17, 2024

Exchange Income Corp (EIF-T) QuotePress Release - The Globe and Mail

Oct 17, 2024
pulisher
Oct 16, 2024

Cocoa #7 (CAU21) Quote - The Globe and Mail

Oct 16, 2024
pulisher
Oct 13, 2024

Wendy Pizarro - Los Angeles Times

Oct 13, 2024
pulisher
Oct 11, 2024

CLDI stock touches 52-week low at $1 amid market challenges - Investing.com Canada

Oct 11, 2024
pulisher
Oct 04, 2024

Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail

Oct 04, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Gains FDA Nod for Brain Cancer Trial - TipRanks

Sep 30, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 - U.S. Politics Today

Sep 30, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma - The Manila Times

Sep 30, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application - The Bakersfield Californian

Sep 30, 2024
pulisher
Sep 24, 2024

Calidi Biotherapeutics announces board changes and auditor ratification - Investing.com

Sep 24, 2024
pulisher
Sep 12, 2024

Calidi Biotherapeutics Presents Antitumor Virotherapy Advances - TipRanks

Sep 12, 2024
pulisher
Sep 09, 2024

Calidi Biotherapeutics stock target cut by Baird with Outperform tag maintained - Investing.com

Sep 09, 2024
pulisher
Sep 09, 2024

Calidi price target lowered to $2.50 from $20 at Baird - TipRanks

Sep 09, 2024
pulisher
Aug 26, 2024

CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q2 2024 - MSN

Aug 26, 2024
pulisher
Aug 26, 2024

Calidi Biotherapeutics Inc (CLDI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

Aug 26, 2024
pulisher
Aug 23, 2024

CLDI Stock Plummets to 52-Week Low at $1.41 Amid Market Turbulence - Investing.com

Aug 23, 2024
pulisher
Aug 22, 2024

Calidi Biotherapeutics Unveils Redtail Biopharma Subsidiary - TipRanks

Aug 22, 2024
pulisher
Aug 20, 2024

Calidi Biotherapeutics announces board reduction following director's exit By Investing.com - Investing.com South Africa

Aug 20, 2024
pulisher
Aug 20, 2024

Calidi Biotherapeutics announces board reduction following director's exit - Investing.com

Aug 20, 2024
pulisher
Aug 20, 2024

Calidi Biotherapeutics Board Reshuffles as Advisor Departs - TipRanks

Aug 20, 2024

Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$19.00
price up icon 4.27%
$76.98
price up icon 1.23%
$39.53
price up icon 7.03%
$359.21
price down icon 0.88%
$187.76
price down icon 0.58%
$101.83
price up icon 2.00%
Kapitalisierung:     |  Volumen (24h):